Clearside Biomedical Inc (CLSD)
1.035
+0.02
(+2.48%)
USD |
NASDAQ |
Nov 04, 16:00
1.06
+0.02
(+2.42%)
After-Hours: 20:00
Clearside Biomedical Revenue (Quarterly): 0.09M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.09M |
| March 31, 2024 | 0.23M |
| December 31, 2023 | 6.345M |
| September 30, 2023 | 0.859M |
| June 30, 2023 | 1.018M |
| March 31, 2023 | 0.004M |
| December 31, 2022 | 0.33M |
| September 30, 2022 | 0.266M |
| June 30, 2022 | 0.384M |
| March 31, 2022 | 0.347M |
| December 31, 2021 | 25.69M |
| September 30, 2021 | 3.074M |
| June 30, 2021 | 0.78M |
| March 31, 2021 | 0.034M |
| December 31, 2020 | 0.011M |
| September 30, 2020 | 3.432M |
| June 30, 2020 | 0.354M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.097M |
| December 31, 2019 | 1.942M |
| September 30, 2019 | 0.141M |
| June 30, 2019 | 0.045M |
| March 31, 2019 | 0.045M |
| December 31, 2018 | 0.03M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.055M |
| September 30, 2017 | 0.155M |
| June 30, 2017 | 0.13M |
| March 31, 2017 | 0.005M |
| December 31, 2016 | 0.005M |
| September 30, 2016 | 0.005M |
| June 30, 2016 | 0.005M |
| March 31, 2016 | 0.505M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.004M
Minimum
Mar 2023
25.69M
Maximum
Dec 2021
2.594M
Average
0.384M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Viking Therapeutics Inc | -- |
| Arcus Biosciences Inc | 39.00M |
| Crinetics Pharmaceuticals Inc | 0.399M |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.40M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.594M |
| Total Expenses (Quarterly) | 7.68M |
| EPS Diluted (Quarterly) | -0.10 |
| Enterprise Value | 48.00M |
| Profit Margin (Quarterly) | -8.44K% |
| Earnings Yield | -48.31% |
| Normalized Earnings Yield | -48.31 |